IdeS (Imlifidase): A Novel Agent That Cleaves Human IgG and Permits Successful Kidney Transplantation Across High-strength Donor-specific Antibody. [electronic resource]
Producer: 20190822Description: 488-496 p. digitalISSN:- 1528-1140
- Adolescent
- Adult
- Aged
- Bacterial Proteins -- immunology
- Desensitization, Immunologic -- methods
- Endopeptidases -- immunology
- Female
- Graft Rejection -- immunology
- Histocompatibility -- immunology
- Histocompatibility Testing
- Humans
- Immunoglobulin G -- immunology
- Infusions, Intravenous
- Intraoperative Care
- Isoantibodies -- blood
- Kidney Transplantation
- Male
- Middle Aged
- Streptococcus pyogenes
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.